United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 24, 2026 · Filed Aug 25, 2026

On Aug 24, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$511.97 for US$4.86M under a trading plan, leaving 324,443 shares. Filed Aug 25, 2026 (Form 4).

Sold
9,500 shares
Price
US$511.97 average (US$509.41 to US$513.35)
Value
US$4.86M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 24, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 24, 2026Common StockSale224US$509.41333,719Indirect
Aug 24, 2026Common StockSale1,323US$510.52332,396Indirect
Aug 24, 2026Common StockSale3,056US$511.63329,340Indirect
Aug 24, 2026Common StockSale3,592US$512.46325,748Indirect
Aug 24, 2026Common StockSale1,305US$513.35324,443Indirect

Source

View original at SEC

Related